OncoMed Pharmaceuticals SVP/CFO on Emerging Company Capital Formation Testimony

Type:

Video

William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals, highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth. Mr. Waddill provided testimony today on behalf of BIO at a Senate Committee on Banking, Housing, and Urban Affairs hearing.

April 21, 2013 25,000+ One-on-One Partnering meetings are taking place in Chicago	April 21, 2013 Ashley Anderson, Choose Chicago	April 17, 2013 2013 Scientific American Worldview Report	April 15, 2013 What Does Diversity Mean in the 21st Century?
February 12, 2013 Tales From the Wild West (Wing): Reflections from White House Chiefs of Staff Featuring John Podesta & Joshua Bolton	February 12, 2013 Fireside Chat With Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin	February 12, 2013 Orphan Drugs: Making Rare Disease Rarer	February 8, 2013 Kimball Thomson, President & CEO at BioUtah